Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
60 NC counties and 1 VA county are under alert, including Wake, Cumberland, Durham, Johnston, and Orange counties.
Just In
Thunderstorm warning includes most of the Triangle and expires at 2:45
Program
On WRAL at 6: Hundreds of millions of your tax dollars wasted. WRAL Investigates one of the most expensive city projects that went nowhere
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amneal Pharmaceuticals Inc
(NQ:
AMRX
)
7.320
-0.110 (-1.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,145,869
Open
7.400
Bid (Size)
7.120 (1)
Ask (Size)
7.550 (1)
Prev. Close
7.430
Today's Range
7.255 - 7.570
52wk Range
5.010 - 7.735
Shares Outstanding
1,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Amneal to Report Second Quarter 2024 Results on August 9, 2024
July 11, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Launches FOCINVEZ™, the First Ready-to-Use Version of Fosaprepitant
July 09, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Performance
YTD
+22.41%
+22.41%
1 Month
+8.44%
+8.44%
3 Month
+34.07%
+34.07%
6 Month
+39.69%
+39.69%
1 Year
+17.87%
+17.87%
More News
Read More
Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab)
July 01, 2024
From
Kashiv BioSciences, LLC
Via
Business Wire
Amneal Expands Biosimilars Portfolio to Eight Products with Addition of Omalizumab Biosimilar
July 01, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Releases 2023 Environmental, Social and Governance Report
June 28, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
3 Stocks to Buy That Are Up 100% Over the Past 52 Weeks
June 25, 2024
Via
InvestorPlace
Amneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New Therapies
June 05, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.